Total Payments
$28,090
2024 Payments
$787.73
Companies
16
Transactions
139
Medicare Patients
11,968
Medicare Billing
$10.1M
Payment Breakdown by Category
Consulting$20,635 (73.5%)
Food & Beverage$5,279 (18.8%)
Travel$2,082 (7.4%)
Education$93.64 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $20,635 | 5 | 73.5% |
| Food and Beverage | $5,279 | 126 | 18.8% |
| Travel and Lodging | $2,082 | 7 | 7.4% |
| Education | $93.64 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $11,893 | 43 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $7,779 | 11 | $0 (2021) |
| Allergan Inc. | $5,542 | 6 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $735.92 | 34 | $0 (2024) |
| Apellis Pharmaceuticals, Inc. | $592.75 | 9 | $0 (2024) |
| Astellas Pharma US Inc | $345.47 | 13 | $0 (2024) |
| Genentech, Inc. | $314.40 | 3 | $0 (2022) |
| TOPCON MEDICAL SYSTEMS, INC. | $223.79 | 4 | $0 (2017) |
| Spark Therapeutics, Inc. | $137.74 | 2 | $0 (2019) |
| Aerie Pharmaceuticals, Inc. | $125.00 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $787.73 | 31 | Astellas Pharma US Inc ($263.70) |
| 2023 | $637.14 | 16 | Apellis Pharmaceuticals, Inc. ($205.84) |
| 2022 | $6,616 | 23 | Genentech USA, Inc. ($6,076) |
| 2021 | $127.30 | 6 | Regeneron Healthcare Solutions, Inc. ($66.93) |
| 2020 | $1,671 | 5 | Novartis Pharmaceuticals Corporation ($1,633) |
| 2019 | $6,240 | 13 | Novartis Pharmaceuticals Corporation ($6,103) |
| 2018 | $6,515 | 24 | Allergan Inc. ($5,542) |
| 2017 | $5,496 | 21 | Genentech USA, Inc. ($5,077) |
All Payment Transactions
139 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/10/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: Ophthalmology | ||||||
| 12/09/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 11/26/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/18/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/05/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: Ophthalmology | ||||||
| 10/29/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Ophthalmology | ||||||
| 10/25/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: Ophthalmology | ||||||
| 10/17/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/15/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological), EYLEA | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/11/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $32.75 | General |
| Category: Ophthalmology | ||||||
| 10/09/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $33.34 | General |
| Category: Ophthalmology | ||||||
| 10/07/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/02/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/23/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $32.31 | General |
| Category: Ophthalmology | ||||||
| 09/17/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $27.84 | General |
| Category: EYE CARE | ||||||
| 09/04/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $3.25 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/27/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $32.93 | General |
| Category: Ophthalmology | ||||||
| 08/16/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/13/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $27.16 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/24/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/08/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Ophthalmology | ||||||
| 06/11/2024 | Genentech USA, Inc. | Lucentis (Biological), Vabysmo | Food and Beverage | In-kind items and services | $30.49 | General |
| Category: Ophthalmology | ||||||
| 05/07/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: Ophthalmology | ||||||
| 05/01/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological), EYLEA HD | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 3,697 | 24,840 | $5.8M | $3.2M |
| 2022 | 15 | 3,242 | 13,456 | $3.8M | $2.7M |
| 2021 | 14 | 2,712 | 10,345 | $3.0M | $2.3M |
| 2020 | 15 | 2,317 | 9,043 | $2.7M | $1.9M |
Total Patients
11,968
Total Services
57,684
Medicare Billing
$10.1M
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 209 | 2,550 | $2.3M | $1.8M | 75.4% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 40 | 11,820 | $444,991 | $344,000 | 77.3% |
| J3490 | Unclassified drugs | Office | 2023 | 51 | 192 | $995,200 | $309,482 | 31.1% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 33 | 1,060 | $287,849 | $192,856 | 67.0% |
| 67028 | Injection of drug into eye | Office | 2023 | 292 | 1,621 | $844,001 | $182,053 | 21.6% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 614 | 2,283 | $307,645 | $179,189 | 58.2% |
| 92134 | Imaging of retina | Office | 2023 | 825 | 2,817 | $179,844 | $98,738 | 54.9% |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | Office | 2023 | 18 | 480 | $144,000 | $57,773 | 40.1% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 408 | 460 | $77,822 | $45,570 | 58.6% |
| 92250 | Photography of the retina | Office | 2023 | 688 | 919 | $59,972 | $30,443 | 50.8% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 151 | 151 | $68,006 | $18,574 | 27.3% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 79 | 135 | $5,281 | $2,940 | 55.7% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 167 | 222 | $11,527 | $2,878 | 25.0% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 43 | 46 | $5,169 | $2,686 | 52.0% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 48 | 53 | $5,549 | $2,401 | 43.3% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 18 | 18 | $3,321 | $2,277 | 68.5% |
| 92002 | New patient problem focused exam of visual system | Office | 2023 | 13 | 13 | $1,540 | $955.72 | 62.1% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 180 | 2,288 | $2.1M | $1.6M | 76.2% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 55 | 1,779 | $614,816 | $397,409 | 64.6% |
| 67028 | Injection of drug into eye | Office | 2022 | 230 | 1,367 | $238,687 | $149,961 | 62.8% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 430 | 1,709 | $205,069 | $134,767 | 65.7% |
| J3590 | Unclassified biologics | Office | 2022 | 16 | 62 | $137,480 | $98,766 | 71.8% |
| 92134 | Imaging of retina | Office | 2022 | 652 | 2,341 | $127,827 | $84,518 | 66.1% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 443 | 540 | $92,354 | $58,899 | 63.8% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2022 | 13 | 1,620 | $66,258 | $48,343 | 73.0% |
About Dr. Irene Barbazetto, MD
Dr. Irene Barbazetto, MD is a Ophthalmology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2007. The National Provider Identifier (NPI) number assigned to this provider is 1881894566.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Irene Barbazetto, MD has received a total of $28,090 in payments from pharmaceutical and medical device companies, with $787.73 received in 2024. These payments were reported across 139 transactions from 16 companies. The most common payment nature is "Consulting Fee" ($20,635).
As a Medicare-enrolled provider, Barbazetto has provided services to 11,968 Medicare beneficiaries, totaling 57,684 services with total Medicare billing of $10.1M. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location New York, NY
- Active Since 07/20/2007
- Last Updated 10/23/2019
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1881894566
Products in Payments
- Lucentis (Biological) $11,644
- BEOVU (Drug) $7,654
- OZURDEX (Drug) $5,494
- EYLEA (Biological) $353.96
- Syfovre (Drug) $351.59
- Izervay (Drug) $263.70
- EYLEA HD (Biological) $248.58
- DRI-OCT TRITON (Device) $223.79
- Non-Covered Product (Drug) $164.40
- SUSVIMO (Drug) $150.00
- EYLEA AFLIBERCEPT INJECTION (Biological) $133.38
- DUREZOL (Drug) $125.00
- MIEBO (Drug) $125.00
- Rhopressa (Drug) $125.00
- Vabysmo (Drug) $68.86
- VABYSMO (Drug) $67.32
- PROLENSA (Drug) $42.75
- Cimerli (Biological) $37.82
- XDEMVY (Drug) $26.92
- YUTIQ (Drug) $24.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in New York
Dr. Tsontcho Ianchulev, M.d. Mph, M.D. MPH
Ophthalmology — Payments: $21.4M
Ophthalmology $21.4M
Dr. Nathan Radcliffe, M.d, M.D
Ophthalmology — Payments: $2.2M
Ophthalmology $2.2M
Dr. Joshua Young, M.d, M.D
Ophthalmology — Payments: $805,605
Ophthalmology $805,605
Dr. Raymond Fong, M.d, M.D
Ophthalmology — Payments: $581,936
Ophthalmology $581,936
Joseph Panarelli, M.d, M.D
Ophthalmology — Payments: $525,201
Ophthalmology $525,201
David Guyer
Ophthalmology — Payments: $491,407
Ophthalmology $491,407